Product information

Naropin 2 mg/ml
5 x 100 ml
ropivacaïne
1554419
0 / 10
Locked

Product properties

98717-15-8
N01BB09
Sandoz
Solution for injection
BE177247
05060249176190
M44
Public
177247-01

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Other reason) and no stock is available from wholesalers. Switching to an alternative is necessary.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Other reason

Alternative available
Available
Until 28/02/2026

Composition

3 ingredients

Substance Type Strength CAS
Active ingredient
132112-35-7
Excipient
8.6 mg/mL
Excipient

Additional information

View on BCPI

Availability statistics

Commercialization stopped
277 days
3
0
01/03/2026